The Masimo W1 advanced health tracking watch. Credit: Masimo / Business Wire.

The Department of Anaesthesiology at the Lausanne University Hospital (CHUV) in Switzerland has incorporated the Masimo W1 advanced health tracking watch into its pre-surgical patient assessment research programme.

Led by CHUV anesthesiology head professor Patrick Schoettker, the initiative aims to provide anaesthesiologists and surgical teams with better insights into patients’ physiological status before surgery, with the goal of improving outcomes.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Masimo founder and CEO Joe Kiani said: “We are excited to deepen our relationship with anaesthesiologists at the CHUV and to help them leverage Masimo W1’s health tracking capabilities to help perioperative teams establish more insightful baseline physiological data about their patients.  

“The baseline data can then allow clinicians to know what is normal and abnormal for each patient they care for in the hospital.  

“Also, with Masimo W1, they can remotely monitor the patient post-surgery at home, when appropriate, and reduce how long the patient remains in the hospital.”

See Also:

The Masimo W1 watch is claimed to provide accurate and continuous measurements of key physiological parameters, integrating with the Masimo SafetyNet remote patient management platform.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Last year, CHUV launched a programme that focuses on leveraging innovative technologies to identify areas for health and behaviour improvements in individual patients.

Through the collection and analysis of demographic, vital signs, and behaviour optimisation data, the team aims to offer personalised management throughout the anaesthesia and surgical process.

As part of the programme, patients scheduled for elective surgery will receive Masimo W1 watches two weeks before their procedure to establish baseline vital signs data.

This information will be relayed to clinicians during the preoperative anaesthesia visit, allowing the perioperative team to develop a comprehensive physiological profile and make more informed care decisions.